Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc.

PBSV - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.45M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Pharma-Bio Serv, Inc.Pharma-Bio Serv, Inc.-1.415%0%--
$0.19

Current Fair Value

60.7% downside

Overvalued by 60.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$11.45 Million
Enterprise Value$75.09 Million
Annual dividend$0.07
Dividend yield15.00%
Earnings per Share$0
Beta0.71
Outstanding Shares22,901,692

Return

Return on Equity-0.13%ROE
Return on Assets-0.12%
Return on Invested Capital-0.00%

Valuation & Multiples

P/E Ratio-1.39P/E Ratio
PEG-0.02PEG
Price to Sales-Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue7.92
Enterprise Value to EBIT-484.61
Enterprise Value to Net Income-6
Total Debt to Enterprise0.87
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 14, 2026
EPS
-$0.00
Est. $0.03
Revenue
$2.30 M
Est. $2.70 M

Next Earnings Call

Expected Date
February 4, 2027
EPS Estimate
$0.03
Consensus analyst estimate
Revenue Estimate
$2.70 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Pharma-Bio Serv, Inc.

55 employees
CEO: Victor Sanchez

Pharma-Bio Serv, Inc. functions as a specialized consulting firm, providing services focused on regulatory compliance and the transfer of technology. The company offers its compliance expertise to a diverse range of clients, including th...